Purpose Management of giant cell arteritis (GCA, Horton's disease) involves many
uncertainties. This work was undertaken to establish French recommendations for GCA …

Glucocorticoids remain the cornerstone of medical therapy in giant cell arteritis (GCA) and
should be started immediately to prevent severe consequences of the disease, such as …

Giant cell arteritis (GCA) is a common form of vasculitis that predominantly affects the
elderly. Cranial symptoms and elevated inflammatory markers are suggestive of the …

The Diagnosis and Treatment of Giant Cell Arteritis - PMC Back to Top Skip to main content NIH
NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …

Giant cell arteritis (GCA) is a chronic systemic vasculitis with a marked female predominance
and restriction to old age. The disease process distinctly targets large and medium sized …

Giant cell arteritis (GCA) is the most common vasculitis affecting people older than 50 years.
The last decades have shed new light on the clinical paradigm of this condition, expanding …

Historically, giant cell arteritis (GCA) was considered to be synonymous with temporal
arteritis. However, the disease spectrum of GCA extends much further, and includes …

Giant cell arteritis is a chronic vasculitis affecting large and medium-sized arteries, most
commonly the temporal and other cranial arteries. Temporal artery biopsy has long been the …

Giant cell arteritis (GCA), the most common form of systemic vasculitis in adults,
preferentially involves large and medium-sized arteries in patients over the age of 50. The …

Objective: To develop evidence-based guidelines for the management of giant cell arteritis
(GCA) as a complement to guidelines in other areas of rheumatology, issued by the Swedish …